From the Harvard Medical School, Division of Plastic Surgery, Brigham & Women’s Hospital, and the Department of Dermatology, Beth Israel Deaconess Medical Center.
Received for publication March 10, 2020; accepted August 13, 2020.
Related digital media are available in the full-text version of the article on www.PRSJournal.com.
By reading this article, you are entitled to claim one (1) hour of Category 2 Patient Safety Credit. ASPS members can claim this credit by logging in to PlasticSurgery.org Dashboard, clicking “Submit CME,” and completing the form.
Disclosure:E.M.T., R.H., and K.M.K. have no financial disclosures relevant to the content of this article. D.P.O. receives research funding from Acelity, Inc., through grants to Brigham and Women’s Hospital. A.B.K. is on the Board of Directors of Almirall, a consultant and an investigator for Novartis, Abbvie, UCB, Pfizer, Lilly, and Janssen, and has fellowship funding from Janssen and Abbvie.
Dennis P. Orgill, M.D., Ph.D., Division of Plastic Surgery, Brigham & Women’s Hospital, 75 Francis Street, Boston, Mass. 02115, [email protected]